Nuvectis Pharma, Inc.NVCTNASDAQ
LOADING
|||
Net Income Growth Accelerating
Above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-17.81%
↑ 99% above average
Average (18q)
-1359.31%
Historical baseline
Range
High:51.56%
Low:-25717.39%
Volatility
-1895.7%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -17.81% |
| Q2 2025 | -18.79% |
| Q1 2025 | 14.66% |
| Q4 2024 | -50.45% |
| Q3 2024 | 6.21% |
| Q2 2024 | -6.16% |
| Q1 2024 | 37.01% |
| Q4 2023 | -12.60% |
| Q3 2023 | -3.03% |
| Q2 2023 | -40.97% |
| Q1 2023 | 39.53% |
| Q4 2022 | -13.94% |
| Q3 2022 | -64.67% |
| Q2 2022 | -21.27% |
| Q1 2022 | -30.16% |
| Q4 2021 | 51.56% |
| Q3 2021 | 21.39% |
| Q2 2021 | -25717.39% |
| Q1 2021 | 0.00% |